Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation

@article{Kalgutkar2007GenotoxicityO2,
  title={Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation},
  author={Amit S. Kalgutkar and Deepak K. Dalvie and Jiri Aubrecht and Evan B. Smith and Stephanie L. Coffing and Jennifer R. Cheung and Chandra Vage and Mary E. Lame and Phoebe Chiang and Kim F McClure and Tristan S. Maurer and Richard V Coelho and Victor F. Soliman and Klaas Schildknegt},
  journal={Drug Metabolism and Disposition},
  year={2007},
  volume={35},
  pages={848 - 858}
}
2-(3-Chlorobenzyloxy)-6-(piperazin-1-yl)pyrazine (3) is a potent and selective 5-HT2C agonist that exhibits dose-dependent inhibition of food intake and reduction in body weight in rats, making it an attractive candidate for treatment of obesity. However, examination of the genotoxicity potential of 3 in the Salmonella Ames assay using tester strains TA98, TA100, TA1535, and TA1537 revealed a metabolism (rat S9/NADPH)- and dose-dependent increase of reverse mutations in strains TA100 and TA1537… 

Figures and Tables from this paper

Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate.

It was concluded that 1 also had the potential to be mutagenic in humans based on observing the endocyclic iminium ion following incubation with a human liver S9 preparation and the commensurate detection of DNA adducts.

Signal Transduction Mechanism for Serotonin 5-HT2B Receptor-Mediated DNA Synthesis and Proliferation in Primary Cultures of Adult Rat Hepatocytes.

The results suggest that the proliferative mechanism of activating 5-HT is mediated mainly through5-HT2B receptor-stimulated Gq/PLC and EGF/TGF-α-receptor/phosphatidylinositol 3-kinase (PI3K)/ERK2/mammalian target of rapamycin (mTOR) signaling pathways in primary cultured hepatocytes.

Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors.

A series of 4-substituted pyrimido[4,5-d]azepines that are potent, selective 5-HT2C receptor partial agonists is described, and homology modeling has been carried out to rationalize binding and agonist efficacy of these compounds.

Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.

The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold.

A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]cysteine and [14C]cyanide.

The value obtained from the [(35)S]cysteine trapping assay in human liver microsomes predicted potential for covalent binding of the test compounds to proteins with reasonable accuracy.

Bioactivation II: Phase I (Non-P450)

The focus of this chapter is on highlighting specific examples of the less-appreciated non-P450 drug-metabolizing enzymes, and the potential role these enzymes may play in bioactivation and toxicity.

Biotransformation and bioactivation reactions of alicyclic amines in drug molecules

The current review provides a comprehensive summary of biotransformation and bioactivation pathways of aliphatic nitrogen containing heterocycles and strategies to mitigate metabolic liabilities.

References

SHOWING 1-10 OF 28 REFERENCES

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.

Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole.

Kinetic studies showed that while HC-QM reacts rapidly with water, the model o-quinone, which cannot isomerize to a quinone methide, was remarkably resistant to hydrolysis.

Pyrimido[1,2-alpha]purin-10(3H)-one: a reactive electrophile in the genome.

1 is an electrophile in the human genome that may react with cellular nucleophiles to form novel cross-linked adducts and is reported that 1 reacts at neutral pH with hydroxylamines to form oximes.

Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan.

It is demonstrated that the reactive cis-2-butene-1,4-dial formed during the microsomal oxidation of furan reacts rapidly and completely with amino acid residues to form pyrrole and pyrrolin- 2-one derivatives.

WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity

Ways-163909 decreased food intake in obese Zucker rats and diet-induced obese mice with ED50 values of 1.4 and 5.19 mg/kg i.p., consistent with the potential utility of 5-HT2C receptor agonists as anti-obesity agents.

Oxidation of eugenol to form DNA adducts and 8-hydroxy-2'-deoxyguanosine: role of quinone methide derivative in DNA adduct formation.

It is demonstrated that eugenol can be activated to form both DNA adducts and oxidative base damage and proposed that the formation of this DNA damage may contribute to the observed toxic properties of e Eugenol.

Identification of cis-2-butene-1,4-dial as a microsomal metabolite of furan.

The hepatocarcinogen furan is believed to be activated to the reactive aldehyde, cis-2-butene-1,4-dial, by microsomal enzymes. The rat liver microsomal metabolism of furan was examined in the

Alkylation of amino acids and glutathione in water by o-quinone methide. Reactivity and selectivity.

These are the first direct reaction rate measurements of nucleophilic addition to the parent o-quinone methide, and a thermal and photochemical reversibility of the alkylation process opens a new perspective for the use and application of such adducts as o-QM molecular carriers.

5-HT2C receptor agonists as potential drugs for the treatment of obesity.

  • M. Bickerdike
  • Biology, Psychology
    Current topics in medicinal chemistry
  • 2003
Both the pre-clinical and clinical evidence supporting the use of 5-HT(2C) receptor agonists for the treatment of obesity is reviewed and the developments that have been made to date are assessed.

Evidence that the anorexia induced by lipopolysaccharide is mediated by the 5-HT2C receptor